CH Biotech R&D Co., Ltd. (TPE:6534)

CH Biotech R&D Revenue

CH Biotech R&D had revenue of 420.48M TWD in the quarter ending June 30, 2025, with 4.93% growth. This brings the company's revenue in the last twelve months to 1.68B, up 13.79% year-over-year. In the year 2024, CH Biotech R&D had annual revenue of 1.64B with 7.98% growth.

• Revenue (ttm): 1.68B
• Revenue Growth: +13.79%
• P/S Ratio: 6.90
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.64B	120.91M	7.98%
Dec 31, 2023	1.51B	80.71M	5.63%
Dec 31, 2022	1.43B	415.61M	40.81%
Dec 31, 2021	1.02B	316.32M	45.05%
Dec 31, 2020	702.19M	-138.49M	-16.47%